Structure elucidation of trace amount of impurities in drugs using Co-Sense for LC-MS system

Significance of the topic

The reliable identification and structural elucidation of trace impurities in pharmaceutical products are essential for ensuring drug safety, efficacy, and regulatory compliance. Conventional HPLC methods often rely on non-volatile buffers that are incompatible with mass spectrometry, necessitating complex off-line desalting and concentration steps that increase analysis time and risk sample loss or degradation.

Objectives and study overview

This application note introduces the Co-Sense for LC-MS system, designed to automate online solid-phase extraction, desalting, concentration, and re-separation of trace impurities prior to mass spectrometric analysis. The aim is to detect impurities at levels of 0.1% or lower relative to the main drug substance, while simplifying sample preparation and improving sensitivity.

Methodology and instrumentation used

The Co-Sense system employs a tandem HPLC configuration with three connected LC modules and multiple switching valves (V1–V5). Key steps include:

• Fractionation of the target impurity from a non-volatile buffer-based mobile phase in the first LC column (C1).
• Online dilution, trapping of the fraction on a second column (C2), and removal of phosphate salts.
• Elution of the purified impurity with methanol into a third semi-micro column (C3) optimized for LC-MS compatibility.

The mass spectrometer used is a Shimadzu single-quadrupole QP8000α capable of ESI and APCI ionization. Analytical conditions are summarized as follows:

• Column1: Shim-pack VP-ODS, 4.6×150 mm, phosphate buffer/methanol (45:55), 1.0 mL/min, 40 °C.
• Column2: Shim-pack GVP-ODS, 2.0×5.0 mm, water dilution, 1.0 mL/min, room temperature.
• Column3: Shim-pack VP-ODS, 2.0×150 mm, methanol, 0.2 mL/min, 40 °C.
• APCI positive mode: probe +4.5 kV, 400 °C; CDL 230 °C, scan m/z 10–550.

Main results and discussion

In the analysis of a pharmaceutical sample, the main component eluted at 8.9 min, while a trace impurity (Compound A) at 0.15% UV area ratio was isolated at 5.9 min. After online desalting and concentration, the recombined fraction yielded a clear UV chromatogram and total ion chromatogram. MS data confirmed a protonated molecule [M+H]+ at m/z 231, consistent with the proposed structure of Compound A.

Benefits and practical applications of the method

• Automated online desalting and concentration reduce manual handling and sample loss.
• Large-volume injections in the first LC enable detection of ultra-trace impurities.
• Re-separation in a third LC ensures compatibility with MS and improves spectral clarity.
• Applicable to unstable compounds that degrade under conventional off-line prep.

Future trends and potential applications

Integration of online sample preparation with advanced high-resolution mass spectrometry and data-driven workflows is expected to further enhance impurity profiling. Adaptation of the Co-Sense approach to bioanalytical, metabolomic, and environmental analyses may broaden its utility.

Conclusion

The Co-Sense for LC-MS system offers a fully automated, three-step process for desalting, concentration, and re-separation of trace impurities, enabling sensitive and efficient structural elucidation in drug development and quality control.

References

No specific literature references were provided in the original document.